70. GLP-1: Alcohol, Depression and Online Shopping
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
GLP-1 drugs, like Ozempic and semaglutide, are doing more than just shrinking waistlines.
Recent data suggests they are actively rewiring the human brain. In this deep dive, we explore how these medications affect the brain's reward system, potentially dampening cravings and shifting behaviors related to addiction, alcohol consumption, and depression.
Key Topics Covered
The Brain's Reward Dial: Understanding how GLP-1s interact with the brain's reward system to help manage cravings.
Substance Use & Alcohol: Examining clinical data that shows a reduction in alcohol consumption and substance use in patients taking these drugs.
Impact on Depression: Discussing how these medications may interrupt the cycle between craving and consumption, leading to significant changes in mood and behavior.
Mechanism of Action: A look at how GLP-1 receptors in the brain's immune cells may help reduce neuroinflammation and improve mitochondrial function.
DisclaimerWe are not medical professionals; we are curious guides synthesizing a stack of recent clinical trials, surveys, and pre-prints for you. Please always consult your doctor about your own health.
Would you like me to draft a short, punchy social media post to accompany this Spotify release?